The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma - Dummer, R; Guminski, A; Gutzmer, R (J Am Acad Dermatol, 2016)